Those “other” included miscellaneous cardiovascular agents, vasodilators, vasopressors, agents for pulmonary hypertension, aldosterone receptor antagonists, and renin inhibitors; and they were not considered in this study. Here, NR3C2 is linked to pulmonary hypertension.